{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:23:29Z","timestamp":1790447009260,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000381","name":"Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["59"],"award-info":[{"award-number":["59"]}],"id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/Fellowship\/0038\/2016"],"award-info":[{"award-number":["NMRC\/Fellowship\/0038\/2016"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5255\/A15935"],"award-info":[{"award-number":["C5255\/A15935"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"polish ministry of science","award":["1070\/MOB\/B\/2013\/0"],"award-info":[{"award-number":["1070\/MOB\/B\/2013\/0"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40478-017-0495-8","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T20:14:59Z","timestamp":1512504899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease"],"prefix":"10.1186","volume":"5","author":[{"given":"Maciej","family":"Jurynczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8580-2023","authenticated-orcid":false,"given":"Fay","family":"Probert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrong","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim D. W.","family":"Claridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Woodhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"DeLuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola R.","family":"Sibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Isabel Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"495_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/acn3.94","volume":"1","author":"DC Anthony","year":"2014","unstructured":"Anthony DC, Dickens AM, Seneca N, Couch Y, Campbell S, Checa B, Kersemans V, Warren EA, Tredwell M, Sibson NR, Gouverneur V, Leppert D (2014) Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain. Ann Clin Transl Neurol 1:659\u2013669. \nhttps:\/\/doi.org\/10.1002\/acn3.94","journal-title":"Ann Clin Transl Neurol"},{"key":"495_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.atherosclerosissup.2005.02.004","volume":"6","author":"P Barter","year":"2005","unstructured":"Barter P (2005) The inflammation: lipoprotein cycle. Atheroscler Suppl 6:15\u201320. \nhttps:\/\/doi.org\/10.1016\/j.atherosclerosissup.2005.02.004","journal-title":"Atheroscler Suppl"},{"key":"495_CR3","doi-asserted-by":"publisher","unstructured":"Chanson JB, Alame M, Collongues N, Blanc F, Fleury M, Rudolf G, de Seze J, Vincent T (2013) Evaluation of clinical interest of anti-aquaporin-4 autoantibody followup in neuromyelitis optica. Clin Dev Immunol 2013:146219. doi:\nhttps:\/\/doi.org\/10.1155\/2013\/146219","DOI":"10.1155\/2013\/146219"},{"key":"495_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ana.23909","volume":"74","author":"O Ciccarelli","year":"2013","unstructured":"Ciccarelli O, Thomas DL, De Vita E, Wheeler-Kingshott CA, Kachramanoglou C, Kapoor R, Leary S, Matthews L, Palace J, Chard D, Miller DH, Toosy AT, Thompson AJ (2013) Low myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica. Ann Neurol 74:301\u2013305. \nhttps:\/\/doi.org\/10.1002\/ana.23909","journal-title":"Ann Neurol"},{"key":"495_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545\u2013558. \nhttps:\/\/doi.org\/10.1038\/nri3871","journal-title":"Nat Rev Immunol"},{"key":"495_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11481-015-9622-0","volume":"10","author":"AM Dickens","year":"2015","unstructured":"Dickens AM, Larkin JR, Davis BG, Griffin JL, Claridge TD, Sibson NR, Anthony DC (2015) NMR-based metabolomics separates the distinct stages of disease in a chronic relapsing model of multiple sclerosis. J NeuroImmune Pharmacol 10:435\u2013444. \nhttps:\/\/doi.org\/10.1007\/s11481-015-9622-0","journal-title":"J NeuroImmune Pharmacol"},{"key":"495_CR7","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1212\/WNL.0000000000000905","volume":"83","author":"AM Dickens","year":"2014","unstructured":"Dickens AM, Larkin JR, Griffin JL, Cavey A, Matthews L, Turner MR, Wilcock GK, Davis BG, Claridge TD, Palace J, Anthony DC, Sibson NR (2014) A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology 83:1492\u20131499. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000000905","journal-title":"Neurology"},{"key":"495_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/01.mol.0000217891.92993.53","volume":"17","author":"I Dobreva","year":"2006","unstructured":"Dobreva I, Waeber G, Widmann C (2006) Lipoproteins and mitogen-activated protein kinase signaling: a role in atherogenesis. Curr Opin Lipidol 17:110\u2013121. \nhttps:\/\/doi.org\/10.1097\/01.mol.0000217891.92993.53","journal-title":"Curr Opin Lipidol"},{"key":"495_CR9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0026-0495(88)90067-4","volume":"37","author":"WH Ettinger Jr","year":"1988","unstructured":"Ettinger WH Jr, Hazzard WR (1988) Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 37:1055\u20131058","journal-title":"Metabolism"},{"key":"495_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1471-4159.2010.06982.x","volume":"115","author":"N Farooqi","year":"2010","unstructured":"Farooqi N, Gran B, Constantinescu CS (2010) Are current disease-modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis? J Neurochem 115:829\u2013844. \nhttps:\/\/doi.org\/10.1111\/j.1471-4159.2010.06982.x","journal-title":"J Neurochem"},{"key":"495_CR11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/brain\/awh153","volume":"127","author":"KT Fernando","year":"2004","unstructured":"Fernando KT, McLean MA, Chard DT, MacManus DG, Dalton CM, Miszkiel KA, Gordon RM, Plant GT, Thompson AJ, Miller DH (2004) Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 127:1361\u20131369. \nhttps:\/\/doi.org\/10.1093\/brain\/awh153","journal-title":"Brain"},{"key":"495_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jns.2011.09.004","volume":"311","author":"G Ferretti","year":"2011","unstructured":"Ferretti G, Bacchetti T (2011) Peroxidation of lipoproteins in multiple sclerosis. J Neurol Sci 311:92\u201397. \nhttps:\/\/doi.org\/10.1016\/j.jns.2011.09.004","journal-title":"J Neurol Sci"},{"key":"495_CR13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1471-4159.2002.01041.x","volume":"82","author":"SK Fisher","year":"2002","unstructured":"Fisher SK, Novak JE, Agranoff BW (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82:736\u2013754","journal-title":"J Neurochem"},{"key":"495_CR14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0889-8529(05)70023-2","volume":"27","author":"HN Ginsberg","year":"1998","unstructured":"Ginsberg HN (1998) Lipoprotein physiology. Endocrinol Metab Clin N Am 27:503\u2013519","journal-title":"Endocrinol Metab Clin N Am"},{"key":"495_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","volume":"89","author":"Y Hacohen","year":"2017","unstructured":"Hacohen Y, Mankad K, Chong WK, Barkhof F, Vincent A, Lim M, Wassmer E, Ciccarelli O, Hemingway C (2017) Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Neurology 89:269\u2013278. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000004117","journal-title":"Neurology"},{"key":"495_CR16","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.neuroimage.2010.10.017","volume":"54","author":"M Haris","year":"2011","unstructured":"Haris M, Cai K, Singh A, Hariharan H, Reddy R (2011) In vivo mapping of brain myo-inositol. NeuroImage 54:2079\u20132085. \nhttps:\/\/doi.org\/10.1016\/j.neuroimage.2010.10.017","journal-title":"NeuroImage"},{"key":"495_CR17","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1093\/brain\/awn240","volume":"131","author":"S Jarius","year":"2008","unstructured":"Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131:3072\u20133080. \nhttps:\/\/doi.org\/10.1093\/brain\/awn240","journal-title":"Brain"},{"key":"495_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 6:383\u2013392. \nhttps:\/\/doi.org\/10.1038\/nrneurol.2010.72","journal-title":"Nat Rev Neurol"},{"key":"495_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep43410","volume":"7","author":"W Jorissen","year":"2017","unstructured":"Jorissen W, Wouters E, Bogie JF, Vanmierlo T, Noben JP, Sviridov D, Hellings N, Somers V, Valcke R, Vanwijmeersch B, Stinissen P, Mulder MT, Remaley AT, Hendriks JJ (2017) Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL. Sci Rep 7:43410. \nhttps:\/\/doi.org\/10.1038\/srep43410","journal-title":"Sci Rep"},{"key":"495_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","volume":"86","author":"M Jurynczyk","year":"2015","unstructured":"Jurynczyk M, Craner M, Palace J (2015) Overlapping CNS inflammatory diseases: differentiating features of NMO and MS. J Neurol Neurosurg Psychiatry 86:20\u201325. \nhttps:\/\/doi.org\/10.1136\/jnnp-2014-308984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"495_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/brain\/aww350","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G, DeLuca G, Chandratre S, Leite MI, Vincent A, Palace J (2017) Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain 140:617\u2013627. \nhttps:\/\/doi.org\/10.1093\/brain\/aww350","journal-title":"Brain"},{"key":"495_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/jnnp-2016-314005","volume":"88","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Tackley G, Kong Y, Geraldes R, Matthews L, Woodhall M, Waters P, Kuker W, Craner M, Weir A, DeLuca GC, Kremer S, Leite MI, Vincent A, Jacob A, de Seze J, Palace J (2017) Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease. J Neurol Neurosurg Psychiatry 88:132\u2013136. \nhttps:\/\/doi.org\/10.1136\/jnnp-2016-314005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"495_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/684903","volume":"2013","author":"H Kaji","year":"2013","unstructured":"Kaji H (2013) High-density lipoproteins and the immune system. J Lipids 2013:684903. \nhttps:\/\/doi.org\/10.1155\/2013\/684903","journal-title":"J Lipids"},{"key":"495_CR24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archneur.56.3.311","volume":"56","author":"A Karni","year":"1999","unstructured":"Karni A, Bakimer-Kleiner R, Abramsky O, Ben-Nun A (1999) Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch Neurol 56:311\u2013315","journal-title":"Arch Neurol"},{"key":"495_CR25","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1177\/1352458514566666","volume":"21","author":"IA Ketelslegers","year":"2015","unstructured":"Ketelslegers IA, Van Pelt DE, Bryde S, Neuteboom RF, Catsman-Berrevoets CE, Hamann D, Hintzen RQ (2015) Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort. Mult Scler 21:1513\u20131520. \nhttps:\/\/doi.org\/10.1177\/1352458514566666","journal-title":"Mult Scler"},{"key":"495_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181758","volume":"12","author":"HH Kim","year":"2017","unstructured":"Kim HH, Jeong IH, Hyun JS, Kong BS, Kim HJ, Park SJ (2017) Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance. PLoS One 12:e0181758. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0181758","journal-title":"PLoS One"},{"key":"495_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000121","volume":"2","author":"J Kitley","year":"2015","unstructured":"Kitley J, Woodhall M, Leite MI, Palace J, Vincent A, Waters P (2015) Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO. Neurol Neuroimmunol Neuroinflamm 2:e121. \nhttps:\/\/doi.org\/10.1212\/NXI.0000000000000121","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"495_CR28","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Palace J, Vincent A (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:1273\u20131277. \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e31826aac4e","journal-title":"Neurology"},{"key":"495_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/archneurol.2011.216","volume":"69","author":"I Kleiter","year":"2012","unstructured":"Kleiter I, Hellwig K, Berthele A, Kumpfel T, Linker RA, Hartung HP, Paul F, Aktas O, Neuromyelitis Optica Study G (2012) Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neurol 69:239\u2013245. \nhttps:\/\/doi.org\/10.1001\/archneurol.2011.216","journal-title":"Arch Neurol"},{"key":"495_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473\u2013477. \nhttps:\/\/doi.org\/10.1084\/jem.20050304","journal-title":"J Exp Med"},{"key":"495_CR31","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet"},{"key":"495_CR32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0731-7085(03)00410-2","volume":"33","author":"EM Lenz","year":"2003","unstructured":"Lenz EM, Bright J, Wilson ID, Morgan SR, Nash AF (2003) A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal 33:1103\u20131115","journal-title":"J Pharm Biomed Anal"},{"key":"495_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.clineuro.2010.03.017","volume":"112","author":"Y Li","year":"2010","unstructured":"Li Y, Wang H, Hu X, Peng F, Yang Y (2010) Serum lipoprotein levels in patients with neuromyelitis optica elevated but had little correlation with clinical presentations. Clin Neurol Neurosurg 112:478\u2013481. \nhttps:\/\/doi.org\/10.1016\/j.clineuro.2010.03.017","journal-title":"Clin Neurol Neurosurg"},{"key":"495_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bpa.12099","volume":"24","author":"CF Lucchinetti","year":"2014","unstructured":"Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T (2014) The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol 24:83\u201397. \nhttps:\/\/doi.org\/10.1111\/bpa.12099","journal-title":"Brain Pathol"},{"key":"495_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S Mader","year":"2011","unstructured":"Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8:184. \nhttps:\/\/doi.org\/10.1186\/1742-2094-8-184","journal-title":"J Neuroinflammation"},{"key":"495_CR36","volume-title":"Characteristic Compostion of myelin. In: basic neurochemistry: molecular, cellular adn medical aspects. 6th edition","author":"PQ,RH Morell","year":"1999","unstructured":"Morell PQ,RH (1999) Characteristic Compostion of myelin. In: basic neurochemistry: molecular, cellular adn medical aspects. 6th edition. Lippincott-Raven, Philadelphia"},{"key":"495_CR37","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/1352458513504638","volume":"20","author":"FM Moussallieh","year":"2014","unstructured":"Moussallieh FM, Elbayed K, Chanson JB, Rudolf G, Piotto M, De Seze J, Namer IJ (2014) Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis. Mult Scler 20:558\u2013565. \nhttps:\/\/doi.org\/10.1177\/1352458513504638","journal-title":"Mult Scler"},{"key":"495_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tcm.2005.05.008","volume":"15","author":"M Navab","year":"2005","unstructured":"Navab M, Anantharamaiah GM, Fogelman AM (2005) The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med 15:158\u2013161. \nhttps:\/\/doi.org\/10.1016\/j.tcm.2005.05.008","journal-title":"Trends Cardiovasc Med"},{"key":"495_CR39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2990.1994.tb01174.x","volume":"20","author":"J Newcombe","year":"1994","unstructured":"Newcombe J, Li H, Cuzner ML (1994) Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol 20:152\u2013162","journal-title":"Neuropathol Appl Neurobiol"},{"key":"495_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm1488","volume":"13","author":"KC O'Connor","year":"2007","unstructured":"O'Connor KC, McLaughlin KA, De Jager PL, Chitnis T, Bettelli E, Xu C, Robinson WH, Cherry SV, Bar-Or A, Banwell B, Fukaura H, Fukazawa T, Tenembaum S, Wong SJ, Tavakoli NP, Idrissova Z, Viglietta V, Rostasy K, Pohl D, Dale RC, Freedman M, Steinman L, Buckle GJ, Kuchroo VK, Hafler DA, Wucherpfennig KW (2007) Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 13:211\u2013217. \nhttps:\/\/doi.org\/10.1038\/nm1488","journal-title":"Nat Med"},{"key":"495_CR41","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","volume":"67","author":"J Palace","year":"2010","unstructured":"Palace J, Leite MI, Nairne A, Vincent A (2010) Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol 67:1016\u20131017. \nhttps:\/\/doi.org\/10.1001\/archneurol.2010.188","journal-title":"Arch Neurol"},{"key":"495_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00529","volume":"8","author":"P Peschl","year":"2017","unstructured":"Peschl P, Bradl M, Hoftberger R, Berger T, Reindl M (2017) Myelin Oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front Immunol 8:529. \nhttps:\/\/doi.org\/10.3389\/fimmu.2017.00529","journal-title":"Front Immunol"},{"key":"495_CR43","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292\u2013302. \nhttps:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"key":"495_CR44","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","volume":"77","author":"AK Probstel","year":"2011","unstructured":"Probstel AK, Dornmair K, Bittner R, Sperl P, Jenne D, Magalhaes S, Villalobos A, Breithaupt C, Weissert R, Jacob U, Krumbholz M, Kuempfel T, Blaschek A, Stark W, Gartner J, Pohl D, Rostasy K, Weber F, Forne I, Khademi M, Olsson T, Brilot F, Tantsis E, Dale RC, Wekerle H, Hohlfeld R, Banwell B, Bar-Or A, Meinl E, Derfuss T (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77:580\u2013588. \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e318228c0b1","journal-title":"Neurology"},{"key":"495_CR45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","volume":"15","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Dale RC, Brilot F (2016) Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev 15:307\u2013324. \nhttps:\/\/doi.org\/10.1016\/j.autrev.2015.12.004","journal-title":"Autoimmun Rev"},{"key":"495_CR46","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, Nakashima I, Apostolos-Pereira SL, Talim N, Simm RF, Lino AM, Misu T, Leite MI, Aoki M, Fujihara K (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82:474\u2013481. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000000101","journal-title":"Neurology"},{"key":"495_CR47","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ab.2003.10.033","volume":"325","author":"H Tang","year":"2004","unstructured":"Tang H, Wang Y, Nicholson JK, Lindon JC (2004) Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem 325:260\u2013272","journal-title":"Anal Biochem"},{"key":"495_CR48","unstructured":"Team RC R: A Language and Environment for Statistical Computing. R Found Stat Comput"},{"key":"495_CR49","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1021\/acs.jproteome.5b00354","volume":"14","author":"EA Thevenot","year":"2015","unstructured":"Thevenot EA, Roux A, Xu Y, Ezan E, Junot C (2015) Analysis of the human adult urinary Metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for Univariate and OPLS statistical analyses. J Proteome Res 14:3322\u20133335. \nhttps:\/\/doi.org\/10.1021\/acs.jproteome.5b00354","journal-title":"J Proteome Res"},{"key":"495_CR50","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000317","volume":"4","author":"P Valentino","year":"2017","unstructured":"Valentino P, Marnetto F, Granieri L, Capobianco M, Bertolotto A (2017) Aquaporin-4 antibody titration in NMO patients treated with rituximab: a retrospective study. Neurol Neuroimmunol Neuroinflamm 4:e317. \nhttps:\/\/doi.org\/10.1212\/NXI.0000000000000317","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"495_CR51","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1212\/01.wnl.0000316195.52001.e1","volume":"71","author":"H Wang","year":"2008","unstructured":"Wang H, Munger KL, Reindl M, O'Reilly EJ, Levin LI, Berger T, Ascherio A (2008) Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 71:1142\u20131146. \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000316195.52001.e1","journal-title":"Neurology"},{"key":"495_CR52","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, Jurynczyk M, Tackley G, Rocha J, Takahashi T, Misu T, Nakashima I, Palace J, Fujihara K, Leite MI, Vincent A (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89. \nhttps:\/\/doi.org\/10.1212\/NXI.0000000000000089","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"495_CR53","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"PJ Waters","year":"2012","unstructured":"Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ (2012) Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78:665\u2013671; discussion 669. \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e318248dec1","journal-title":"Neurology"},{"key":"495_CR54","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp-2012-304740","volume":"84","author":"B Weinstock-Guttman","year":"2013","unstructured":"Weinstock-Guttman B, Zivadinov R, Horakova D, Havrdova E, Qu J, Shyh G, Lakota E, O'Connor K, Badgett D, Tamano-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Ramanathan M (2013) Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry 84:1186\u20131191. \nhttps:\/\/doi.org\/10.1136\/jnnp-2012-304740","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"495_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1212\/01.wnl.0000254502.87233.9a","volume":"68","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG (2007) A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 68:603\u2013605. \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000254502.87233.9a","journal-title":"Neurology"},{"key":"495_CR56","doi-asserted-by":"publisher","first-page":"D801","DOI":"10.1093\/nar\/gks1065","volume":"41","author":"DS Wishart","year":"2013","unstructured":"Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, Bouatra S, Sinelnikov I, Arndt D, Xia J, Liu P, Yallou F, Bjorndahl T, Perez-Pineiro R, Eisner R, Allen F, Neveu V, Greiner R, Scalbert A (2013) HMDB 3.0--the human Metabolome database in 2013. Nucleic Acids Res 41:D801\u2013D807. \nhttps:\/\/doi.org\/10.1093\/nar\/gks1065","journal-title":"Nucleic Acids Res"},{"key":"495_CR57","doi-asserted-by":"publisher","first-page":"D603","DOI":"10.1093\/nar\/gkn810","volume":"37","author":"DS Wishart","year":"2009","unstructured":"Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37:D603\u2013D610. \nhttps:\/\/doi.org\/10.1093\/nar\/gkn810","journal-title":"Nucleic Acids Res"},{"key":"495_CR58","doi-asserted-by":"publisher","first-page":"D521","DOI":"10.1093\/nar\/gkl923","volume":"35","author":"DS Wishart","year":"2007","unstructured":"Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, Fung C, Nikolai L, Lewis M, Coutouly MA, Forsythe I, Tang P, Shrivastava S, Jeroncic K, Stothard P, Amegbey G, Block D, Hau DD, Wagner J, Miniaci J, Clements M, Gebremedhin M, Guo N, Zhang Y, Duggan GE, Macinnis GD, Weljie AM, Dowlatabadi R, Bamforth F, Clive D, Greiner R, Li L, Marrie T, Sykes BD, Vogel HJ, Querengesser L (2007) HMDB: the human Metabolome database. Nucleic Acids Res 35:D521\u2013D526. \nhttps:\/\/doi.org\/10.1093\/nar\/gkl923","journal-title":"Nucleic Acids Res"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T20:15:52Z","timestamp":1512504952000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-017-0495-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["495"],"URL":"https:\/\/doi.org\/10.1186\/s40478-017-0495-8","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"95"}}